Cargando…

Vitreous and Plasma VEGF Levels as Predictive Factors in the Progression of Proliferative Diabetic Retinopathy after Vitrectomy

PURPOSE: To investigate the vitreous and plasma levels of vascular endothelial growth factor (VEGF) in patients with proliferative diabetic retinopathy (PDR) and to determine whether they predict a disease prognosis after primary vitrectomy. METHODS: Fifty patients (50 eyes) with PDR who underwent p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jiaxing, Chen, Song, Jiang, Feng, You, Caiyun, Mao, Chunjie, Yu, Jinguo, Han, Jindong, Zhang, Zhuhong, Yan, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199758/ https://www.ncbi.nlm.nih.gov/pubmed/25329921 http://dx.doi.org/10.1371/journal.pone.0110531

Ejemplares similares

Early Vitreous Hemorrhage after Vitrectomy with Preoperative Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
por: Sato, Tatsuhiko, et al.
Publicado: (2013)

Plasma and Vitreous Metabolomics Profiling of Proliferative Diabetic Retinopathy
por: Wang, Hanying, et al.
Publicado: (2022)

Correlation of Aqueous, Vitreous, and Plasma Cytokine Levels in Patients With Proliferative Diabetic Retinopathy
por: Wu, Frances, et al.
Publicado: (2020)

Cytokine Levels in Human Vitreous in Proliferative Diabetic Retinopathy
por: Loporchio, Dean F., et al.
Publicado: (2021)

Effect of intravitreal triamcinolone acetonide injection at the end of vitrectomy for vitreous haemorrhage related to proliferative diabetic retinopathy
por: Takamura, Yoshihiro, et al.
Publicado: (2018)

The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage
por: Li, Shengguo, et al.
Publicado: (2022)

Infographic: intravitreous aflibercept vs vitrectomy with panretinal photocoagulation for vitreous haemorrhage from proliferative diabetic retinopathy
por: Song, Anna, et al.
Publicado: (2021)

Factors related to postoperative vitreous hemorrhage after small-gauge vitrectomy in proliferative diabetic retinopathy patients
por: Zhao, Meng, et al.
Publicado: (2023)

Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients
por: Izuta, Hiroshi, et al.
Publicado: (2009)

VEGF-Independent Activation of Müller Cells by the Vitreous from Proliferative Diabetic Retinopathy Patients
por: Rezzola, Sara, et al.
Publicado: (2021)

Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients
por: Liao, Mengyu, et al.
Publicado: (2020)

A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy
por: Qiu, Chang-Yu, et al.
Publicado: (2022)

Refining vitrectomy for proliferative diabetic retinopathy
por: Chen, San-Ni, et al.
Publicado: (2023)

Proliferative diabetic retinopathy and relations among antioxidant activity, oxidative stress, and VEGF in the vitreous body
por: Izuta, Hiroshi, et al.
Publicado: (2010)

Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy
por: Chernykh, VV, et al.
Publicado: (2015)

Effect of intravitreal conbercept injection on VEGF-A and -B levels in the aqueous and vitreous humor of patients with proliferative diabetic retinopathy
por: Zhang, Yunda, et al.
Publicado: (2021)

Characterisation of the vitreous proteome in proliferative diabetic retinopathy
por: Wang, Hao, et al.
Publicado: (2012)

Elevated vitreous Lipocalin-2 levels of patients with proliferative diabetic retinopathy
por: Wang, Hui, et al.
Publicado: (2020)

Overexpression p21WAF1/CIP1 in suppressing retinal pigment epithelial cells and progression of proliferative vitreoretinopathy via inhibition CDK2 and cyclin E
por: Wang, Ying, et al.
Publicado: (2014)

Postvitrectomy diabetic vitreous hemorrhage in proliferative diabetic retinopathy
por: Shi, Lei, et al.
Publicado: (2012)

Complement Activation in the Vitreous of Patients With Proliferative Diabetic Retinopathy
por: Mandava, Nikhil, et al.
Publicado: (2020)

Vitrectomy for Proliferative Diabetic Retinopathy Associated with Klinefelter Syndrome
por: Tajiri, Kensuke, et al.
Publicado: (2015)

Long‐term outcomes of vitrectomy for proliferative diabetic retinopathy
por: Schreur, Vivian, et al.
Publicado: (2020)

Comparative Analysis of the Effects of the Anti-VEGF Drug and Glucocorticoid by Injection before the End of Vitrectomy for Proliferative Diabetic Retinopathy
por: Zhao, Haijin, et al.
Publicado: (2021)

Combined Use of Anti-VEGF Drugs Before and During Pars Plana Vitrectomy for Severe Proliferative Diabetic Retinopathy
por: Sun, Xincheng, et al.
Publicado: (2023)

Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study
por: Takayama, Kei, et al.
Publicado: (2019)

Identification of Chemokines and Growth Factors in Proliferative Diabetic Retinopathy Vitreous
por: Dai, Ying, et al.
Publicado: (2014)

Eicosanoid Profiles in the Vitreous Humor of Patients with Proliferative Diabetic Retinopathy
por: Lin, Albert L, et al.
Publicado: (2020)

Levosulpiride Increases the Levels of Prolactin and Antiangiogenic Vasoinhibin in the Vitreous of Patients with Proliferative Diabetic Retinopathy
por: Nuñez-Amaro, Carlos D., et al.
Publicado: (2020)

Increased Angiopoietin-1 and -2 levels in human vitreous are associated with proliferative diabetic retinopathy
por: Tsai, Teresa, et al.
Publicado: (2023)

Predictors of postoperative bleeding after vitrectomy for vitreous hemorrhage in patients with diabetic retinopathy
por: Motoda, Saori, et al.
Publicado: (2018)

Roles of elevated intravitreal IL-1β and IL-10 levels in proliferative diabetic retinopathy
por: Mao, Chunjie, et al.
Publicado: (2014)

Visual outcomes and complications following one-way air-fluid exchange technique for vitreous hemorrhage post vitrectomy in proliferative diabetic retinopathy patients
por: Wang, Qun, et al.
Publicado: (2021)

Retracted: Comparative Analysis of the Effects of the Anti-VEGF Drug and Glucocorticoid by Injection before the End of Vitrectomy for Proliferative Diabetic Retinopathy
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy
por: Kwon, Jin-woo, et al.
Publicado: (2017)

Pars Plana Vitrectomy Reoperations for Complications of Proliferative Diabetic Retinopathy
por: Al-khersan, Hasenin, et al.
Publicado: (2020)

Post-vitrectomy delayed retinal breaks in proliferative diabetic retinopathy
por: Venkatesh, Ramesh, et al.
Publicado: (2023)

microRNA Expression Profile in the Vitreous of Proliferative Diabetic Retinopathy Patients and Differences from Patients Treated with Anti-VEGF Therapy
por: Friedrich, Julian, et al.
Publicado: (2020)

Angiogenic and Vasculogenic Factors in the Vitreous from Patients with Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Vitreous hemorrhage in diabetes patients with proliferative diabetic retinopathy undergoing hemodialysis
por: Kameda, Yusuke, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qsi71gvimournom6mcr60s69tb